Table 2. Birth characteristics and early neonatal and maternal outcomes of the study groups.
| Variables | Group 1 (n=258) | Group 2 (n=35) | Total (n=293) | p-value | |
|---|---|---|---|---|---|
| Cesarean delivery | 175 (67.8) | 27 (77.1) | 202 (68.9) | 0.356 | |
| GAB (weeks) | 36 (34–38) | 34 (31.25–35) | 36 (33–38) | <0.001 | |
| PTB | 32 (12.4%) | 7 (20%) | 39 (13.3%) | 0.285 | |
| <34 weeks | 4 (12.5%) | 1 (14.3%) | 5 (12.8%) | >0.05 | |
| ≥34 weeks | 28 (87.5%) | 6 (85.7%) | 34 (87.2%) | ||
| Birthweight (g) | 3,465 (3,205–3,755) | 3,605 (3,300–3,960) | 3,490 (3,212.5–3,790) | 0.085 | |
| APGAR 1 | 9 (9–9) | 9 (9–9) | 9 (9–9) | 0.325 | |
| APGAR 5 | 10 (10–10) | 10 (10–10) | 10 (10–10) | 0.363 | |
| Female gender | 106 (41.1) | 15 (42.9) | 121 (42.3) | 0.987 | |
| NICU admission | 21 (8.1) | 5 (14.3) | 26 (8.9) | 0.215 | |
| Hypoglycemia | 0 (0) | 2 (5.7) | 2 (0.7) | 0.014 | |
| Hyperbilirubinemia | 4 (1.6) | 1 (2.9) | 5 (1.7) | 0.473 | |
| RDS | 9 (3.5) | 2 (5.7) | 11 (3.8) | 0.627 | |
| CNO | 22 (8.5%) | 5 (14.3%) | 27 (9.2%) | 0.344 | |
| PROM | 16 (6%) | 1 (2.9%) | 17 (5.6%) | 0.704 | |
| HDP | 3 (1.2%) | 1 (2.9%) | 4 (1.4%) | 0.400 | |
| PPH | 4 (1.6%) | 1 (2.9%) | 5 (1.7) | 0.473 | |
| CMO | 21 (8.1%) | 2 (5.7%) | 23 (7.8%) | 1.000 | |
APGAR: appearance, pulse, grimace, activity, and respiration score; CMO: composite maternal outcome; CNO: composite neonatal outcome; GAB: gestational age at birth; HDP: hypertensive disorders in pregnancy; NICU: neonatal intensive care unit; PHA: polyhydramnios; PPH: postpartum hemorrhage; PROM: premature rupture of membranes; PTB: preterm birth; RDS: respiratory distress syndrome. Data are expressed as median (Q1–Q3) or number (percentage) where appropriate. A p<0.05 indicates a significant difference. Statistically significant p-values are indicated in bold.